Add time:09/09/2019 Source:sciencedirect.com
Swainsonine (9) is an important mannosidase inhibitor that has been examined clinically as an anticancer drug. The preparation of analogs of swainsonine bearing a hydroxymethyl group at C(3), i.e., (3R)-3-(hydroxymethyl)swainsonine [(10), (3R)-HMS] and (3S)-3-(hydroxymethyl)swainsonine [(11), (3S)-HMS] is described. The synthesis of each analog begins with D-ribose, and involves a Claisen rearrangement, a Sharpless osmylation, and a reductive double-cyclization of either an azido mesylate bearing a lactone (i.e. 24 ⇒ 11) or an azido epoxide bearing a lactone (i.e. 27 ⇒ 10). Both (3R)-HMS and (3S)-HMS were found to be effective inhibitors of α-mannosidase from jack bean.
We also recommend Trading Suppliers and Manufacturers of (3R)-2,3-Dihydro-6-hydroxy-3-(hydroxymethyl)-2-methyl-10H-3α,10aα-epidithiopyrazino[1,2-a]indole-1,4-dione (cas 1668-07-1). Pls Click Website Link as below: cas 1668-07-1 suppliers
About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia
Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog
©2008 LookChem.com,License: ICP
NO.:Zhejiang16009103
complaints:service@lookchem.com Desktop View